Alaunos Therapeutics, Inc.
TCRT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001107421
No open-market purchases or sales by Alaunos Therapeutics, Inc. insiders were filed in the last 90 days; 29 institutions reported holding it in 13F filings for Q2 2026, worth $204.4K in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding Alaunos Therapeutics, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Of which not filed for Q1 2024 | Q1 2024 | Change |
|---|---|---|---|---|
| Holders | 86 | 1 | 46 | −39 |
| SharesConverted for a 1-for-15 split | 2.75M | 950 | 2.35M | −402.0K (−14.6%) |
| Value | $2.96M | $1.01K | $4.23M | +$1.28M (+43.2%) |
1 institution that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (8)
Institutions that held Alaunos Therapeutics, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Virtu Financial LLC | 15,440 | $28.0K | 0.00% |
| Fortis Group Advisors, LLC | 13,999 | $25.3K | 0.00% |
| Dimensional Fund Advisors LP | 12,993 | $23.5K | 0.00% |
| NBC Securities, Inc. | 200 | $1.00K | 0.00% |
| Simplex Trading, LLC | 865 | $1.00K | 0.00% |
| Harbour Investments, Inc. | 466 | $843 | 0.00% |
| Sound Income Strategies, LLC | 48 | $87 | 0.00% |
| Central Trust Co | 10 | $19 | 0.00% |
Sold out (47)
Institutions that held Alaunos Therapeutics, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
Not filed for Q1 2024 yet (1)
Institutions that held Alaunos Therapeutics, Inc. at the end of Q4 2023 and haven't filed a 13F for Q1 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Sawtooth Solutions, LLC | 14,250 | $1.01K |